Kistler Tiffany Companies LLC raised its position in Colgate-Palmolive (NYSE:CL) by 75.9% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,178 shares of the company’s stock after purchasing an additional 1,803 shares during the quarter. Kistler Tiffany Companies LLC’s holdings in Colgate-Palmolive were worth $304,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently made changes to their positions in the company. Bristlecone Advisors LLC increased its stake in shares of Colgate-Palmolive by 5.5% during the third quarter. Bristlecone Advisors LLC now owns 34,511 shares of the company’s stock valued at $2,514,000 after acquiring an additional 1,790 shares during the period. Meeder Asset Management Inc. acquired a new position in shares of Colgate-Palmolive during the third quarter valued at approximately $171,000. Fisher Asset Management LLC increased its stake in shares of Colgate-Palmolive by 3.7% during the third quarter. Fisher Asset Management LLC now owns 245,596 shares of the company’s stock valued at $17,892,000 after acquiring an additional 8,797 shares during the period. Robeco Institutional Asset Management B.V. increased its stake in shares of Colgate-Palmolive by 1.5% during the third quarter. Robeco Institutional Asset Management B.V. now owns 677,486 shares of the company’s stock valued at $49,354,000 after acquiring an additional 9,822 shares during the period. Finally, Assenagon Asset Management S.A. acquired a new position in shares of Colgate-Palmolive during the third quarter valued at approximately $8,760,000. Institutional investors own 72.96% of the company’s stock.

In related news, insider Victoria L. Dolan sold 9,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 14th. The shares were sold at an average price of $73.41, for a total value of $660,690.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Victoria L. Dolan sold 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, November 9th. The stock was sold at an average price of $73.07, for a total transaction of $730,700.00. Following the completion of the transaction, the insider now directly owns 60,528 shares of the company’s stock, valued at approximately $4,422,780.96. The disclosure for this sale can be found here. Insiders sold a total of 181,048 shares of company stock valued at $13,168,995 in the last ninety days. Company insiders own 1.02% of the company’s stock.

Colgate-Palmolive (CL) opened at $74.05 on Friday. Colgate-Palmolive has a 52 week low of $63.43 and a 52 week high of $77.27. The company has a debt-to-equity ratio of 24.42, a current ratio of 1.23 and a quick ratio of 0.92. The company has a market cap of $65,023.68, a P/E ratio of 25.80, a P/E/G ratio of 3.39 and a beta of 0.81.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, October 27th. The company reported $0.73 EPS for the quarter, hitting analysts’ consensus estimates of $0.73. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The firm had revenue of $3.97 billion during the quarter, compared to analyst estimates of $3.94 billion. During the same quarter last year, the business posted $0.73 EPS. The company’s revenue was up 2.8% on a year-over-year basis. analysts forecast that Colgate-Palmolive will post 2.88 earnings per share for the current fiscal year.

A number of research analysts recently commented on CL shares. Zacks Investment Research upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $81.00 price objective on the stock in a research note on Monday, October 23rd. Morgan Stanley upgraded shares of Colgate-Palmolive from an “equal weight” rating to an “overweight” rating and raised their target price for the stock from $75.00 to $84.00 in a report on Monday, September 25th. KeyCorp restated a “hold” rating on shares of Colgate-Palmolive in a report on Monday, October 16th. Stifel Nicolaus set a $73.00 target price on shares of Colgate-Palmolive and gave the stock a “hold” rating in a report on Sunday, October 29th. Finally, Deutsche Bank started coverage on shares of Colgate-Palmolive in a report on Wednesday. They set a “hold” rating and a $75.00 target price for the company. Two analysts have rated the stock with a sell rating, fifteen have given a hold rating and four have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average target price of $76.04.

COPYRIGHT VIOLATION NOTICE: “Kistler Tiffany Companies LLC Has $304,000 Holdings in Colgate-Palmolive (CL)” was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece of content on another site, it was stolen and republished in violation of international copyright and trademark law. The legal version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/12/17/kistler-tiffany-companies-llc-has-304000-holdings-in-colgate-palmolive-cl.html.

Colgate-Palmolive Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Stock Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related stocks with our FREE daily email newsletter.